புற தலையீடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from புற தலையீடு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In புற தலையீடு Today - Breaking & Trending Today

BD Announces Second Fiscal Quarter Results; Reaffirms Fiscal 2021 Guidance


BD Announces Second Fiscal Quarter Results; Reaffirms Fiscal 2021 Guidance
- Second fiscal quarter revenues of $4.9 billion grew 15.4% on a reported basis. On a currency-neutral basis, revenues increased 12.2%.
- BD s COVID-19 testing sales were $480 million, including BD Veritor™ Plus System revenues of $290 million.
- BD s core growth led by strong growth in Medication Delivery Solutions (up 10.4%), Pharmaceutical Systems (up 15.4%), and Biosciences (up 16.3%) on a reported basis.
- Second fiscal quarter GAAP diluted earnings per share (EPS) increased 77.4% year-over-year to $0.94.
- Adjusted EPS increased 25.1% year-over-year to $3.19.
- BD is reaffirming its fiscal 2021 revenue growth and adjusted EPS guidance.
News provided by
Share this article ....

Franklin Lakes , New Jersey , United States , Certest Biotec , Tom Polen , Troy Kirkpatrick , Kristenm Stewart , George Floyd , Solutions Inc , National Asian Pacific American Women Forum , Global Technology Innovation Award , Medication Management Solutions , World Of Health , Justice Initiative , Medication Delivery Solutions , Drug Administration , United Negro College Fund , World Health Organization , Scanwell Health , Bd Life Sciences , Exchange Commission , Life Sciences , European Union Medical Device Regulation , United States Food , Fiscal Quarter , Pharmaceutical Systems ,

BD Announces 510(k) Clearance of Pristine™ Long-Term Hemodialysis Catheter


Share this article
Share this article
FRANKLIN LAKES, N.J., April 14, 2021 /PRNewswire/  BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Pristine™ Long-Term Hemodialysis Catheter, a new hemodialysis catheter with a unique side-hole free symmetric Y-Tip™ distal lumen design. The Pristine™ Catheter will be available in the U.S. in May 2021. The device was developed by Pristine Access Technologies, Ltd., a privately-owned company based in Israel, which was acquired by BD in July 2020 as part of the company s ongoing growth strategy focused on tuck-in acquisitions and R&D investments in improved treatments for chronic diseases. ....

United States , Paul Tyahla , Padraic Obrien , Kristenm Stewart , Pristine Access Technologies Ltd , Padraico Brien , Worldwide President , Peripheral Intervention , Michael Tal , Pristine Access Technologies , ஒன்றுபட்டது மாநிலங்களில் , உலகளவில் ப்ரெஸிடெஂட் , புற தலையீடு , மைக்கேல் தால் ,